Portfolio Analysis and Planning for Pharma and Biotechs
Consulting to strengthen your pipeline by evaluating gaps, opportunities, and redundancies in your portfolio.

Want to learn more?


We help you understand how market dynamics, clinical innovations, and competitive threats affect the future potential for your products, so you can prioritise your pipeline and align your portfolio with your business strategy.

Key features

Deep knowledge of market characteristics and dynamics

Anticipate and manage challenges around your target market, thanks to our vast experience in oncology and rare diseases.

Collaboration, expertise and efficiency

Make confident decisions, with help from our clinical, epidemiology, access and forecasting experts.

Robust and comprehensive data sources

We will apply data from the most appropriate of a broad range of sources, to best meet your requirements.

More information
  • Assessing pipeline composition and gap analysis
  • Appraising the landscape, competitive market and market access
  • Evaluating product clinical utility and commercial value
  • opportunities
  • Forecasting revenues, and valuing assets


We have over 25 years of experience in oncology. Our teams are made up of over 100 oncology specialists, many with advanced degrees and commercial pharma experience. Their collective experience bring a holistic perspective to your engagement that is unbiased and rooted in local and global data.

We support our engagements with accurate and reliable data from a range of sources, including CancerMPact®, CancerLandscape®, and Epi Database®.

We use a holistic approach, integrating the appropriate experts and data to meet your requirements.

Related solutions
Strategic and tactical support to evaluate in/out licensing opportunities and the commercial potential for pharma assets.